2015 American Transplant Congress
Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Transplantation, UCLA, Los Angeles, CA.
Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…2015 American Transplant Congress
Serum Phosphorus Level Has Bidirectional Association With Graft Failure and Mortality in Kidney Transplant Recipients
Hyperphosphatemia in kidney transplant recipients (KTRs) is known to predict a graft and patient survival in several studies. However, studies concerned with hypophosphatemia are scarce.…2015 American Transplant Congress
Cardiac Troponin T (cTNT) in the Assessment of Kidney Transplant (KTx) Benefit and Risk
1Nephrology, Mayo Clinic, Rochester, MN; 2Surgery, Mayo Clinic, Rochester, MN.
Introduction. Compared to waiting list (WL) KTx improves patient survival. However, mortality may increase early post-KTx. cTNT level at candidate evaluation is a strong, independent…2015 American Transplant Congress
Associations Between Sirolimus Use and Outcomes After Liver Transplant for Hepatocellular Carcinoma
A growing fraction of U.S. liver transplants are being done for the indication of hepatocellular carcinoma (HCC). HCC recurrence after transplant remains a major concern…2015 American Transplant Congress
Retransplantation of the Elderly Diabetic: To Do Or Not to Do?
Division of Nephrology, University of Michigan, Ann Arbor, MI.
INTRODUCTION: An increasingly common cause of transplantation is retransplantation. Often, a dilemma exists as to which patients should be considered for retransplantation especially when the…2015 American Transplant Congress
Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?
Surgery, Boston Children's Hospital, Boston, MA.
Examine the relationship between transplant-related total cost and 1-year graft failure and patient mortality rate for liver transplantation at freestanding children's hospitals.Using the Pediatric Health…2015 American Transplant Congress
The Losing Trifecta: Age ≥70, Deceased Donor Transplant, and Delayed Graft Function
Columbia University, New York.
INTRO: Patients ≥70 are the fastest growing part of the ESRD population. Although historically patients ≥70 have had acceptable renal transplant outcomes, in our own…2015 American Transplant Congress
Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients
Graft failure risk peaks during emerging adulthood (18-25 y) in kidney transplant recipients. The association between age and graft failure risk in liver transplant recipients…2015 American Transplant Congress
Superior Outcomes of Kidney Transplantation Compared With Dialysis in Korea: A Propensity–Matched Analysis of a National Population-Based Cohort Study Between 2005 and 2008
Background: Kidney transplantation (KT) can improve clinical outcomes in patients with end-stage renal disease. However, the data about KT outcome comparing with dialysis is rare…2015 American Transplant Congress
Cancer Mortality Among Recipients of Solid Organ Transplant in Ontario
Purpose: Solid organ transplantation recipients (SOTR) have a higher risk of some cancers than the general population, but are also at high risk of mortality…
American Transplant Congress abstracts